Rayzon Medical was established.
Established domestic R&D center
Rayzon was established in 2019 and has operations in Changsha, Beijing, Shanghai, Hong Kong, Germany, etc. We embrace the prin-ciples of patients first, professionalism and innovation. We are an international ophthalmic health technology company that incorpo-rates research and development, manufacture, commercialization, and service.
Rayzon closely collaborates with healthcare providers and research institutions worldwide, striving to develop products that better meet the needs of doctors and patients, and benefit everyone in the world. Through in-house research and development, investments, we have established a rich product line collaborations for optometry and ophthalmology.
Rayzon Medical was established.
Established domestic R&D center
Established domestic manufac-ture base
Established material laboratory
Incorporated raw material enter-prise in Europe
The self-developed orthokera-tology lens entered clinical trial, accelerating business presence in domestic market.
The self-developed scleral lens started
Continued to strengthen pipe-line through
Launched Oculista defocus spec-tacle lenses.
Incorporated ophthalmic knives
Launched Oculista rigid gas permeablecontact lenses for orthokeratology.
Launched Oculista rigid scleral contactlens
2019
2020
2021
2022
2023
2024
2025

To Public

To Patients And Eyecare Professionals

To Employees

To Government